Goldenwell Biotech Inc (GWLL)
0.3275
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Goldenwell Biotech SG&A Expense (Quarterly): 0.0311M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.0311M |
December 31, 2023 | 0.0209M |
September 30, 2023 | 0.0356M |
June 30, 2023 | 0.0272M |
March 31, 2023 | 0.0343M |
December 31, 2022 | 0.9203M |
September 30, 2022 | 0.0276M |
June 30, 2022 | 0.0288M |
Date | Value |
---|---|
March 31, 2022 | 0.0336M |
December 31, 2021 | 0.1028M |
September 30, 2021 | 0.0951M |
June 30, 2021 | 0.0244M |
March 31, 2021 | 0.0469M |
December 31, 2020 | 0.003M |
September 30, 2020 | 0.0009M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.0009M
Minimum
Sep 2020
0.9203M
Maximum
Dec 2022
0.0955M
Average
0.0311M
Median
Mar 2024
SG&A Expense (Quarterly) Benchmarks
Coty Inc | 770.60M |
Bemax Inc | 0.0562M |
e.l.f. Beauty Inc | 210.17M |
Ingles Markets Inc | -- |
Village Super Market Inc | 136.48M |